Myriad Genetics (MYGN) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 8:00 A.M. Mountain Time, with agenda and rules of conduct provided to attendees.

• Opportunity for questions was scheduled for later in the webcast, with adherence to rules emphasized.

Board and executive committee updates

• Introduction of all directors present, including those up for election and new appointments since the previous year.

• Biographical information for officers and directors made available in proxy materials.

Shareholder proposals

• Stockholders voted on five proposals: election of three directors, ratification of auditors, advisory vote on executive compensation, amendment to the 2012 Employee Stock Purchase Plan, and adoption of the 2026 Employee Director and Consultant Equity Incentive Plan.